Bliss GVS Pharma Grants 320,000 Employee Stock Options

Date: August 12, 2026

ESOP Grant Details

The Nomination and Remuneration Committee of Bliss GVS Pharma Limited granted 3,20,000 (Three Lakh Twenty Thousand) stock options under the company's Employee Stock Options Plan 2019 to eligible employees on August 12, 2026.

Key Terms of ESOP Grant

• Total Options Granted: 3,20,000 stock options
• Underlying Shares: 3,20,000 equity shares of Re. 1/- each (each option convertible into one share)
• Exercise Price: ₹43 per option/share
• Pricing Basis: Based on BSE Last Closing Market Price dated August 11, 2026, after deducting 91.32% discount
• Pricing Rationale: To bring uniformity in exercise price of earlier options granted by the company

Vesting Schedule

The options vest in four equal installments over 48 months:

• 25% of total options granted after 12 months from grant date
• 25% of total options granted after 24 months from grant date
• 25% of total options granted after 36 months from grant date
• 25% of total options granted after 48 months from grant date

Exercise and Lock-in Provisions

• Minimum Vesting Period: 1 year between grant and vesting of options
• Exercise Window: Vested options must be exercised within 6 months from vesting date
• Lock-in Period: Equity shares arising from exercised options are subject to 6-month lock-in from allotment date